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The Special Issue, “Development of a National Pediatric Pharmacotherapy Collaborative Practice
Network,” has illuminated the vital global need for better care coordination and interprofessional
collaboration in pharmacotherapy and medication management of children with medical complexity
and special healthcare needs (CSHCN-CMC). From a population health perspective, we identified
how coordination and outcomes might be improved from both practice and research perspectives,
and what tools exist to assist clinical pharmacists and pediatricians to build more durable and
sustainable comprehensive medication management practices around the world [1,2]. The work of the
Professional Compounding Centers of America (PCCA) group [3] and ‘GOLDILOKs’ (Genome and
Ontogeny-Linked Dose Individualization and cLinical Optimization for KidS) Clinic [4] illustrated
personalized approaches to identifying, understanding, and responding to these patients’ unique
drug therapy needs with evidence-based compounded formulations and genome-informed care
planning. Ohio’s Partners for Kids Accountable Care Organization (ACO) provided a comprehensive,
systems-based program for including clinical pharmacists to address inefficiencies in care coordination
and delivery, especially in children with asthma and behavioral health needs [5]. The development
and inclusion of clinical pharmacists within maternal child health strategies of the Health Resources
and Services Administration’s Pediatric Pulmonary Center in Arizona fostered improvements in
community-based, family-centered healthcare for children with chronic respiratory diseases [6].
Clearly, these approaches portend increased responsiveness to unmet drug-related needs at individual
and system levels of analysis.
What’s next? To continue to build on these successes, the following recommendations are offered:
1. Creation of interprofessional communities of practice and research that share tacit knowledge
through various synchronous and asynchronous delivery media to promote point-of-care
collaboration and coordination;
2. Application of administrative leadership and vision that promotes an environment of
innovation through sustainable provider-patient-payer partnerships and outcome-driven
system transformation;
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3. Adoption and expansion of patient engagement functionalities that align with the 21st Century
Cures Act and the World Health Organization’s Convention on the Rights of the Child for
increasing choice, access, equity, and quality in health care.
We believe this modest proposal will generate meaningful improvements that assure all children
receive optimal benefit from pharmacotherapies. We thank the authors and readers of these manuscripts,
and hope that this dialogue will continue to build more durable and sustainable care coordination
systems locally and beyond.
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